Roche proposes novel pricing plan for new drugs

The manufacturer's proposed model is similar to that used in other European countries, where patients get access to new medicines while prices are being negotiated

Susan Mitchell

Deputy Editor and Health Editor @susmitchellsbp
17th December, 2017

Roche, a major global pharmaceutical manufacturer, has urged the government to pilot a new payment model that would enable patients in Ireland to get early access to innovative new drugs.

Roche’s proposed model is similar to that used in other European countries, where patients get access to new medicines while prices are being negotiated.

Roche has a new medicine called Ocrelizumab (trade name Ocrevus), which was recently approved by the European Medicines Agency....

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month, €19.99 Monthly thereafter

Get basic

*New subscribers only

You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

2 Yearly

€315

€248

Unlimited Access for 2 Years

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Share this post

Related Stories

Ireland’s medicinal cannabis scheme needs overhaul, advocate says

Health Eva Short 5 days ago

Some people with cystic fibrosis still awaiting Covid-19 vaccine, charity warns

Health Donal MacNamee 1 week ago

Top medic: ‘If the state can pay for Viagra, it can pay for extreme pregnancy sickness drugs’

Health Daniel Murray 2 weeks ago

Over 300 administered vaccine doses not recorded as given to priority groups

Health Rachel Lavin 2 weeks ago